Related Experiment Videos
Alpha-1-antitrypsin in human brain tumors
Journal of Neurosurgery
|August 1, 1987
Summary
Alpha-1-antitrypsin (alpha 1-AT) is present in most human brain tumors and may protect tumor cells. Higher levels correlate with increased plasminogen activator activity and peritumoral edema.
Area of Science:
- Neuro-oncology
- Biochemistry
- Protease Inhibitors
Background:
- Alpha-1-antitrypsin (alpha 1-AT) is a key protease inhibitor in human plasma.
- Its role in human brain tumors remains largely uncharacterized.
Purpose of the Study:
- To confirm the presence of alpha 1-AT in human brain tumors.
- To investigate the clinical and biological significance of alpha 1-AT in these tumors.
Main Methods:
- Seventy-seven brain tumor patients' samples were analyzed.
- Alpha 1-AT and alpha 2-macroglobulin presence assessed using Ouchterlony immunodiffusion.
- Plasminogen activator (PA) activity measured via gel electrophoresis.
Main Results:
- 68% of brain tumors tested positive for alpha 1-AT; none were positive for alpha 2-macroglobulin.
- Tumors positive for alpha 1-AT showed significantly higher PA activity (p=0.001).
- Elevated peritumoral edema and preoperative serum fibrinogen levels were observed in the alpha 1-AT positive group.
Conclusions:
- Alpha-1-antitrypsin is likely produced by tumor cells in brain tumors.
- Alpha 1-AT may play a role in protecting tumor cells from degradation.
- Its presence correlates with increased proteolytic and inflammatory activity within the tumor microenvironment.